NetworkNewsBreaks – SenesTech Inc. (NASDAQ: SNES

NetworkNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Eyes Significant Interest Since Full Launch of Evolve(TM)

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the innovator of the only EPA-registered contraceptive for male and female rats, recently released its financial results for the 2023 financial year. “Of note was the 80% year-to-date (‘YTD’) revenue growth and the 45.2% year-over-year (‘YOY’) growth in gross profit, a significant milestone which Joel Fruendt, president and CEO of SenesTech, attributed to the development of Evolve(TM), the company’s all-new soft bait product,” a recent article reads. “Since the full launch of Evolve in January 2024, we have seen a significant uptick in interest and orders from a wide range of sales channels and geographies,” Fruendt was quoted as saying. “For instance, we were recently approved as a vendor for a major nationwide hardware retailer; we have signed distribution and stocking agreements for grain management and open field agricultural applications; and we have expanded our geographical reach outside the United States, including Hong Kong, Macau, the United Arab Emirates, Singapore, Australia, New Zealand, and The Netherlands.”

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://nnw.fm/SNES

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer